9 news items
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says
PTPI
17 Jun 24
on transitioning the first-ever prescription ED therapy to OTC status. It targets a significant portion of the multi-billion dollar ED market.
Price Action: PTPI shares closed at $0.41 on Friday.
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
AMSC
AVGO
BITF
13 Jun 24
and raised the price target from $20 to $27.
Neo-Concept International Group Holdings Limited
Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
AEMD
AIU
AVGO
13 Jun 24
candidate MP0712, targeting DLL3.
Longeveron Inc
Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch
PTPI
29 May 24
," "potential," "opportunity," "forecast," "should," "target," "strategy" and similar
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
PTPI
21 May 24
," "forecast," "should," "target," "strategy" and similar expressions, whether in the negative or affirmative, that reflect
slrvcsc399782btp7bx
ME
PTPI
14 May 24
," "forecast," "should," "target," "pursuit," "strategy" and similar expressions, whether in the negative
98oonoo4wl3o0d5r1keqb8ta2
PTPI
23 Apr 24
," "expect," "continue," "potential," "opportunity," "forecast," "should," "target
85anascn32t
PTPI
16 Apr 24
," "forecast," "should," "target," "pursuit," "strategy" and similar expressions, whether
rbapwpuy1hdgzdwzj4col1sbe1ydlzq1t6bbqk rknbklni0u55
ACON
ACORQ
ADTX
2 Apr 24
RH with a Sell and raised the price target from $201 to $264.
MicroStrategy Incorporated
- Prev
- 1
- Next